Other potential target molecules for targeting ovarian cancer cells might include follicle-stimulating hormone receptor (FSHR) [25], intercellular adhesion molecule 1 (ICAM-1) [26], Müllerian inhibiting substance type II receptor (MISIIR) [27], or human epidermal growth factor receptor 2 (HER2) [28]. This evidence concerns the gene ERBB2 and ovarian cancer.